Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi (Q33408772)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi |
scientific article |
Statements
1 reference
Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi (English)
1 reference
Gianluca Gaidano
2 references
Antonio Palumbo
1 reference
Alessandra Tucci
1 reference
Alessia Castellino
1 reference
Vincenzo Pavone
1 reference
Angelo Michele Carella
1 reference
Lorella Orsucci
1 reference
Manuela Zanni
1 reference
Flavia Salvi
1 reference
Anna Marina Liberati
1 reference
Chiara Bottelli
1 reference
Bernardo Rossini
1 reference
Sonia Perticone
1 reference
Pasqualina De Masi
1 reference
Fondazione Italiana Linfomi
1 reference
28 June 2013
1 reference
1 reference
98
1 reference
11
1 reference
1732-1738
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference